Avalon Investment & Advisory’s Dr. Reddy's Laboratories RDY Stock Holding History

Avalon Investment & Advisory’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-40,780	Closed	-$369K	–	373
2016 Q4	$369K	Sell	40,780 -685	-2%	-$6.37K	0.01%	298
2016 Q3	$385K	Sell	41,465 -3,945	-9%	-$37.7K	0.01%	269
2016 Q2	$465K	Buy	45,410 +12,000	+36%	+$110K	0.02%	237
2016 Q1	$302K	Sell	33,410 -780	-2%	-$6.97K	0.01%	227
2015 Q4	$317K	Sell	34,190 -21,365	-38%	-$234K	0.01%	225
2015 Q3	$710K	Buy	55,555 +2,595	+5%	+$32.2K	0.03%	173
2015 Q2	$586K	Buy	52,960 +5,320	+11%	+$58.7K	0.03%	186
2015 Q1	$544K	Buy	47,640 +710	+2%	+$7.53K	0.02%	159
2014 Q4	$474K	Buy	46,930 +6,640	+16%	+$69.9K	0.02%	149
2014 Q3	$423K	Buy	40,290 +7,710	+24%	+$72.5K	0.02%	158
2014 Q2	$281K	Buy	+32,580	New	+$274K	0.01%	168

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Avalon Investment & Advisory's RDY Position: Q1 2017 in Review

Avalon Investment & Advisory sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 40,780 shares — an estimated $369K sold.

Avalon Investment & Advisory first reported a position in RDY in Q2 2014 and held it in 11 quarters. The position peaked at $710K in Q3 2015. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

Avalon Investment & Advisory reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
Avalon Investment & Advisory sold 40,780 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $369K.
Avalon Investment & Advisory first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 11 quarters.
Avalon Investment & Advisory's Dr. Reddy's Laboratories position peaked at $710K in Q3 2015.
134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on Avalon Investment & Advisory's 13F filing for Q1 2017, filed 15 May 2017.